Bayer Aktiengesellschaft (BAYRY)
OTCMKTS
· Delayed Price · Currency is USD
7.72
-0.08 (-1.03%)
Aug 14, 2025, 3:59 PM EDT
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 10.74B EUR in the quarter ending June 30, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to 46.17B, down -1.99% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
46.17B EUR
Revenue Growth
-1.99%
P/S Ratio
0.56
Revenue / Employee
502.63K EUR
Employees
91,864
Market Cap
30.48B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |
Bayer Aktiengesellschaft News
- 1 day ago - Why are Indoco Remedies shares up 2% today? Explained - Business Upturn
- 2 days ago - Bayer and Kumquat Biosciences partner to develop cancer treatment - Seeking Alpha
- 2 days ago - Bayer and Kumquat Biosciences Enter Global Exclusive License and Collaboration in Precision Oncology - Business Wire
- 2 days ago - Bayer inks $1.3 billion deal with Kumquat Biosciences for cancer drug development - Seeking Alpha
- 2 days ago - Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal - Reuters
- 2 days ago - Bayer, Kumquat Biosciences Team Up on New Potential Cancer Drug - WSJ
- 7 days ago - Bayer A.G. (BAYZF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Bayer A.G. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha